Pleurodesis outcome in malignant pleural mesothelioma

被引：43

作者：

Fysh, Edward Thomas Hamilton ^{[1
,2
]}

Tan, Sze Khen ^{[1
,3
]}

Read, Catherine Ann ^{[1
]}

Lee, Felicity ^{[1
]}

McKenzie, Kate ^{[1
]}

Olsen, Nola ^{[4
]}

Weerasena, Indunil ^{[1
]}

Threlfall, Timothy ^{[5
]}

de Klerk, Nicholas ^{[4
]}

Musk, A. William ^{[1
,4
]}

Lee, Y. C. Gary ^{[1
,2
]}

机构：

[1] Sir Charles Gairdner Hosp, Resp Dept, Perth, WA, Australia

[2] Univ Western Australia, Dept Med, Sch Med & Pharmacol, Ctr Asthma Allergy & Resp Res, Perth, WA 6009, Australia

[3] Khoo Teck Puat Hosp, Dept Gen Med, Singapore, Singapore

[4] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia

[5] Western Australia Dept Hlth, Western Australian Canc Registry, Mt Claremont, WA, Australia

来源：

THORAX | 2013年 / 68卷 / 06期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1136/thoraxjnl-2012-203043

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Few data exist on the pleurodesis outcome in patients with malignant pleural mesothelioma (MPM). A retrospective review of the Western Australian Mesothelioma Registry over 5 years revealed 390 evaluable patients. Only a subset of patients (42.3%) underwent pleurodesis, surgically (n=78) or by bedside instillation of sclerosants (n=87). Surgical pleurodesis showed no advantages over bedside pleurodesis in efficacy (32% vs 31% failures requiring further drainage, p=0.98), patient survival (p=0.52) or total time spent in hospital from procedure till death (p=0.36). No clinical, biochemical or radiographic parameters tested adequately predict pleurodesis outcome.

引用

页码：594 / 596

页数：3

共 50 条

[1] OUTCOME OF PLEURODESIS FOR MALIGNANT EFFUSIONS IN MESOTHELIOMA
Fysh, E. T. H.
Tan, S. K.
Read, C. A.
Lee, F.
Mackenzie, K.
Weerasena, I.
Musk, A. W.
Lee, Y. C. G.
RESPIROLOGY, 2012, 17 : 56 - 56
[2] Increased pleural fluid ADA level in patients with malignant mesothelioma: A potential predictor for the outcome of talc pleurodesis
Yildirim, H.
Metintas, M.
Ak, G.
Erginel, M. S.
Kurt, E.
Alatas, F.
Ucgun, I.
LUNG CANCER, 2006, 54 : S18 - S18
[3] Review of malignant pleural mesothelioma survival after talc pleurodesis or surgery
Taioli, Emanuela
van Gerwen, Maaike
Mihalopoulos, Meredith
Moskowitz, Gil
Liu, Bian
Flores, Raja
JOURNAL OF THORACIC DISEASE, 2017, 9 (12) : 5423 - 5433
[4] Pleurodesis in follow-up and treatment of malignant pleural mesothelioma patients
Ak, G.
Metintas, M.
Yildirim, H.
Erginel, S.
Alatas, F.
Metintas, S.
Dundar, E.
LUNG CANCER, 2006, 54 : S17 - S17
[5] Pleurodesis in follow-up and treatment of malignant pleural mesothelioma patients
Ak, Guntulu
Metintas, Muzaffer
Yildirim, Huseyin
Metintas, Selma
Dundar, Emine
Erginel, Sinan
Alatas, Fusun
TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2009, 57 (01): : 22 - 31
[6] Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis
Baud, Mariette
Strano, Salvatore
Dechartres, Agnes
Jouni, Rami
Triponez, Frederic
Chouaid, Christos
Forgez, Patricia
Damotte, Diane
Roche, Nicolas
Regnard, Jean-Francois
Alifano, Marco
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2013, 145 (05): : 1305 - 1311
[7] Neurotensin expression and outcome of malignant pleural mesothelioma
Alifano, Marco
Loi, Mauro
Camilleri-Broet, Sophie
Dupouy, Sandra
Regnard, Jean Francois
Forgez, Patricia
BIOCHIMIE, 2010, 92 (02) : 164 - 170
[8] Pemetrexed in malignant pleural mesothelioma and the clinical outcome
Knuuttila, Aija
Salomaa, Eija-Riitta
Saikkonen, Suvi
Hurme, Saija
Salo, Jarmo
CLINICAL RESPIRATORY JOURNAL, 2012, 6 (02): : 96 - 103
[9] Elastance of the pleural space: A predictor for the outcome of pleurodesis in patients with malignant pleural effusion
Lan, RS
Lo, SK
Chuang, ML
Yang, CT
Tsao, TCY
Lee, CH
ANNALS OF INTERNAL MEDICINE, 1997, 126 (10) : 768 - +
[10] Predictors of talc pleurodesis outcome in patients with malignant pleural effusions
Yildirim, Huseyin
Metintas, Muzaffer
Ak, Guentuelue
Metintas, Selma
Erginel, Sinan
LUNG CANCER, 2008, 62 (01) : 139 - 144

← 1 2 3 4 5 →